Literature DB >> 1415537

Pretranslational regulation of two cardiac glucose transporters in rats exposed to hypobaric hypoxia.

W I Sivitz1, D D Lund, B Yorek, M Grover-McKay, P G Schmid.   

Abstract

To investigate the mechanism by which cardiac glucose utilization increases during hypoxia and increased work load, we studied the effect of 2 and 14 days of hypobaric hypoxia on the expression of two subtypes of the facilitative D-glucose transporter, the GLUT-4 or "insulin-regulatable" isoform and the GLUT-1 isoform thought to mediate basal transport. Rats lose weight when exposed to hypobaric hypoxia, so fasting controls were used in the 2-day studies and pair-fed controls in the 14-day experiments. Hypobaric hypoxia (PO2 69 mmHg) resulted in right ventricular (RV), but not left ventricular (LV), hypertrophy. RV and LV GLUT-1 mRNA levels increased 2- to 3-fold after 2 days and 1.5- to 2-fold after 14 days of hypobaric hypoxia compared with both fasted rats and normal controls. RV GLUT-1 protein increased approximately 3-fold and LV GLUT-1 protein increased 1.5-fold after 14 days of hypobaric hypoxia vs. both pair-fed and normal controls. RV GLUT-4 mRNA decreased to 26% and RV GLUT-4 protein decreased to 54% of normal control levels as a result of 2 days of hypobaric hypoxia. RV GLUT-4 mRNA decreased to 64% of normal control levels with no change in RV GLUT-4 protein as a result of 2 days of fasting. We conclude that hypobaric hypoxia increases cardiac GLUT-1 expression at the pretranslational level in both ventricles. The greater increase in GLUT-1 protein on the right suggests an additive effect of pressure overload. GLUT-4 expression is reduced early in the development of RV hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415537     DOI: 10.1152/ajpendo.1992.263.3.E562

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 2.  Cardiac metabolic adaptations in response to chronic hypoxia.

Authors:  M Faadiel Essop
Journal:  J Physiol       Date:  2007-08-30       Impact factor: 5.182

Review 3.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  Differential responses to chronic hypoxia and dietary restriction of aerobic capacity and enzyme levels in the rat myocardium.

Authors:  Z Daneshrad; M P Garcia-Riera; M Verdys; A Rossi
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

5.  Activating transcription factor 4 is translationally regulated by hypoxic stress.

Authors:  Jaime D Blais; Vasilisa Filipenko; Meixia Bi; Heather P Harding; David Ron; Costas Koumenis; Bradly G Wouters; John C Bell
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

6.  Hypoxia up-regulates triosephosphate isomerase expression via a HIF-dependent pathway.

Authors:  Bernhard Gess; Karl-Heinz Hofbauer; R Deutzmann; Armin Kurtz
Journal:  Pflugers Arch       Date:  2004-02-05       Impact factor: 3.657

7.  Glycolytic inhibition: effects on diastolic relaxation and intracellular calcium handling in hypertrophied rat ventricular myocytes.

Authors:  Y Kagaya; E O Weinberg; N Ito; T Mochizuki; W H Barry; B H Lorell
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 8.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

9.  Role for glucose transporter 1 protein in human breast cancer.

Authors:  M Grover-McKay; S A Walsh; E A Seftor; P A Thomas; M J Hendrix
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 10.  Regulation of cancer metastasis by stress pathways.

Authors:  Keping Xie; Suyun Huang
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.